Concept information
Preferred term
Gadolinium DTPA
Type
-
mesh:Descriptor
Definition
- A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
Broader concept
Entry terms
- 80529-93-7 (Gadolinium DTPA)
- 86050-77-3 (dimeglumine salt)
- 92923-64-3 (di-Na salt)
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- K2I13DR72L
- RH248G8V27
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
80529-93-7 (Gadolinium DTPA)
-
86050-77-3 (dimeglumine salt)
-
92923-64-3 (di-Na salt)
-
Diéthylènetriaminepentaacétate de gadolinium
-
K2I13DR72L
-
Pentétate de gadolinium
-
RH248G8V27
URI
http://data.loterre.fr/ark:/67375/JVR-XBS2BPCZ-F
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}